Stocks Comparison
InnovAge vs LifeStance Health: revenue, profit, margins and growth compared
InnovAge brought in $989.7M of revenue in fiscal 2026, LifeStance Health $1.4B in fiscal 2025. Revenue changed by +15.9% at InnovAge and +13.9% at LifeStance Health on the year before, so InnovAge grew faster. InnovAge kept -0.3% of its revenue as net profit, LifeStance Health 0.7%. Free cash flow was $50.4M at InnovAge and $110M at LifeStance Health.
Side by side, latest fiscal year
| INNV | LFST | |
|---|---|---|
| Fiscal year ended | FY2026 (June 30, 2026) | FY2025 (December 31, 2025) |
| Revenue | $989.7M | $1.4B |
| Revenue growth | +15.9% | +13.9% |
| Net income | -$2.5M | $9.7M |
| Net margin | -0.3% | 0.7% |
| Free cash flow | $50.4M | $110M |
| Free cash flow margin | 5.1% | 7.7% |
| Earnings per share (diluted) | -$0.02 | n/a |
| Cash | $97.9M | $248.6M |
| Debt | $48.8M | $282.8M |
| Price to earnings | n/a | n/a |
| Market value | $1.2B | $4.5B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #145 of 523 · Health care | #126 of 523 · Health care |
Over the years
Questions about InnovAge and LifeStance Health
Which is bigger by revenue, InnovAge or LifeStance Health?
LifeStance Health is bigger by revenue: $1.4B in fiscal 2025, against $989.7M for InnovAge in fiscal 2026.
Which keeps more of its revenue as profit, InnovAge or LifeStance Health?
InnovAge had a net margin of -0.3% in fiscal 2026; LifeStance Health had 0.7% in fiscal 2025.
Which grew revenue faster, InnovAge or LifeStance Health?
In their latest fiscal years revenue changed by +15.9% at InnovAge and +13.9% at LifeStance Health.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.